Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.0925 | 0.1313 |
Brugia malayi | hypothetical protein | 0.0043 | 0.1029 | 0.1029 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.1029 | 0.1029 |
Plasmodium falciparum | phd finger protein, putative | 0.0035 | 0 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.5155 | 0.5155 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0742 | 0.1054 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0049 | 0.1721 | 0.1721 |
Brugia malayi | RNA binding protein | 0.0076 | 0.5155 | 0.5155 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.5155 | 0.5155 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0043 | 0.0925 | 0.1794 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.5155 | 0.5155 |
Onchocerca volvulus | Alhambra homolog | 0.0035 | 0 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.312 | 0.312 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0742 | 0.144 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.314 | 0.6092 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.1029 | 0.1029 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.5155 | 0.5155 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1029 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.5155 | 0.7321 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0742 | 0.0742 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.312 | 0.312 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.1029 | 0.1461 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0043 | 0.0925 | 0.0925 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0115 | 1 | 1 |
Brugia malayi | jmjC domain containing protein | 0.0043 | 0.0925 | 0.0925 |
Echinococcus granulosus | jumonji domain containing protein | 0.0049 | 0.1721 | 0.1721 |
Schistosoma mansoni | jumonji domain containing protein | 0.0092 | 0.7041 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1029 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.0925 | 0.1313 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0115 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.5155 | 0.7321 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.5155 | 0.7321 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.312 | 0.6053 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.5155 | 0.7321 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.468 | 0.9079 |
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.312 | 0.6053 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0035 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1029 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.5155 | 1 |
Giardia lamblia | PHD finger protein 15 | 0.0035 | 0 | 0.5 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0035 | 0 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.5155 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1029 | 0.5 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0043 | 0.0925 | 0.0925 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.5155 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.1029 | 0.1461 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.5155 | 0.7321 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.